The new tool, called a nanobiopsy, uses a robotic glass nanopipette to pierce the cell membrane and extract a volume of around 50 femtolitres, around one per cent of the cell's contents.
It will allow scientists to take samples repeatedly, to study the progression of disease at a molecular level in an individual cell. It can also be used to deliver material into cells, opening up ways to reprogramme diseased cells.
"This is like doing surgery on individual cells," said Dr Paolo Actis, from the Department of Medicine at Imperial College London, who developed the technology with colleagues at the University of California, Santa Cruz.
To get inside the cell, the nanopipette is plunged downwards about one micrometre to pierce the cell membrane.
More From This Section
Applying a voltage across the tip makes fluid flow into the pipette. When the pipette is removed from the cell, the membrane remains intact and the cell retains its shape.
The device is based on a scanning ion conductance microscope, which uses a robotic nanopipette, about 100 nanometres in diameter, to scan the surface of cells.
This measurement is used to guide the tip across the surface of a sample at a constant distance, producing a picture of the surface.
In an initial study published in the journal ACS Nano, the researchers used the nanobiopsy technique to extract and sequence messenger RNA, molecules carrying genetic code transcribed from DNA in the cell's nucleus. This allowed them to see which genes were being expressed in the cell.